Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT07259473 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07259473
Sponsor: Shanghai Zhongshan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric / Gastroesophageal Junction Adenocarcinoma Mismatch Repair Deficient or MSI-High Solid Tumors Immunotherapy

Start date: 2026-01-31
Primary completion: 2029-12-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.